NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED
STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE
PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE
DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE.
PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT 

Oslo, 6 November 2024
The board of directors of Arribatec Group ASA (the "Company") has today, subject
to approval by an Extraordinary General Meeting (the "EGM"), to be held on or
about 2 December 2024, resolved to carry out a rights issue of up to 350 000 000
shares (the "New Shares") with preferential subscription rights for existing
shareholders (the "Rights Issue") to raise gross proceeds of up NOK 35 million.
The subscription price in the Rights Issue is proposed set to NOK 0.10 per New
Share (the "Offer Price").  

The Rights Issue is fully underwritten by key shareholders of the Company (the
"Underwriters"). Underwriters will receive one tradeable unlisted warrant to
subscribe for one new share in the Company for every 2.33 underwritten offer
shares, up to a total of 150 214 592 warrants (norw. frittstående
tegningsretter) (the "Warrants"). 

In addition, the Board proposes to direct an offering to directors of the
Company of up to 60 million New Shares at the Offer Price and 60 million
Warrants on the same terms as the Underwriters (the "Director Offering"). The
participants in the Director Offering will be eligible to receive one -1-
Warrant per New Shares subscribed for in the Director Offering.

The Rights Issue, issue of Warrants and the Director Offering is together
referred to as the "Transaction".

Notice of the EGM, including proposed resolutions regarding the Rights Issue,
the Warrants and the Director Offering, is expected to be sent to the
shareholders on or about 11 November 2024. 

Arctic Securities AS has been engaged as manager for the Rights Issue (the
"Manager"). Ro Sommernes advokatfirma DA is acting as legal advisor to the
Company. 

Background
The Board has recognized that the Company is in need of additional liquidity and
have initiated discussions with its banking partner Danske Bank. The net
proceeds from the Transaction are expected to be applied to strengthen the
Company's liquidity. In addition, Danske Bank have offered amended terms for the
Company's credit facilities which will further increase the liquidity available
to the Company. 

 The amended terms include the following:

o The Company has secured additional liquidity by an extension of its NOK 20
million revolving credit facility 
  until 31 December 2025, and an additional credit facility of NOK 15 million
until 31 January 2025. The credit 
  facility has a coupon of NIBOR + 3.50% plus a 1.00 % commission. 
o The amended terms of the bank debt are conditional upon the Rights Issue being
completed. 
o The Company is exploring to divest non-core business areas if attractive
prices can be achieved. Proceeds are 
  expected to be used to strengthen the balance sheet and reduce any outstanding
amounts under the additional 
  credit facility. 

Subscription price and subscription rights: 

The subscription price for the New Shares to be issued in the Rights Issue and
the Director Offering is proposed set to NOK 0.10 per New Share. 

In order to issue New Shares at NOK 0.10 per Share, the Company needs to reduce
the par value of its shares from NOK 2.80 per Share to NOK 0.10 per share. A
share capital reduction will also be proposed at the EGM to effect this (the
"Share Capital Reduction"). 

Pursuant to section 10-4 of the Norwegian Public Limited Companies Act, the
shareholders of the Company at the date of the EGM, and who are not resident in
a jurisdiction where such offering would be unlawful or, (in jurisdictions other
than Norway) require any prospectus, filing, registration or similar action,
will be granted a preferential right to subscribe for and be allocated the New
Shares in proportion to the number of shares in the Company they own as of that
date, and will according to the board of directors' proposal receive
subscription rights proportionate to their existing shareholding as registered
in the Company's shareholder register in the Norwegian Central Securities
Depository (the VPS) at the expiry of the date of the EGM, currently expected on
4 December 2024 (record date). Provided that a purchase of shares is made with
ordinary T+2 settlement, shares purchased up to and including 2 December 2024
will give the right to receive subscription rights, whereas shares purchased
from and including 3 December 2024, will not give the right to receive
subscription rights. The subscription rights will be sought tradeable and listed
on the Oslo Stock Exchange from and including the first day of the subscription
period and until 16:30 (Oslo time) four trading days prior to the expiry of the
subscription period. Over-subscription will be permitted. Subscription without
subscription rights will not be permitted. 

Subscription Rights will not be issued in the Director Offering.
Oversubscription is not permitted in the Director Offering.

Underwriting: 

Pursuant to, and subject to, the terms and conditions of the underwriting
agreements between the Company and the Underwriters (the "Underwriting
Agreements"), the Underwriters have undertaken on a pro-rata basis (not jointly)
to underwrite an aggregate subscription amount in the Rights Issue of NOK 35
million (the "Total Underwriting Obligation"). Any New Shares subscribed in the
Rights Issue will reduce the underwriting commitment of the Underwriters but not
pre-commitments from existing shareholders. 

Each Underwriter is entitled to an underwriting fee, to be settled in Warrants
issued by the Company. No cash fee is payable for the Underwriting. The
selection of shareholders who have been invited to underwrite has been based on
objective criteria. The Underwriters have undertaken to vote for any shares held
by them at the time of the EGM in favor of the Transaction. 

The Underwriters will, without additional costs, be granted one -1- tradeable
unlisted Warrant for every 2.33 underwritten offer share in the Rights Issue
(rounded down to the nearest whole number of Warrants). 

The Underwriters include, but are not limited to, the investors listed below:

o Ferncliff Listed DAI expects to participate in the underwriting consortium
with a commitment of NOK 19 976 433 
  million in the Rights Issue.
o Titan Ventures expects to participate in the underwriting consortium with a
commitment of NOK 3 584 589 million 
  in the Rights Issue.
o Dallas Asset Management AS expects to participate in the underwriting
consortium with a commitment of NOK 2 500 
  000 million in the Rights Issue.

A complete list of Underwriters will be provided in conjunction with the
Company's EGM and in the Prospectus (defined below).

Terms of the Warrants:
The Warrants issued to the Underwriters and in the Director Offering will, among
other things, have the following terms:

o Each Warrant will give the holder a right to subscribe for one new share in
the Company at Nok 0.10 per Share. 
o The Warrants may be exercised no later than the date that is 12 months from
the date of settlement of the Rights 
  Issue.
o The exercise price shall be subject to Euro-market standard anti-dilution
provisions.

The gross proceeds from the exercise of Warrants will depend on the number of
Warrants exercised. Subsequent exercise of Warrants will increase the gross
proceeds to the Company, which are expected to be used towards the general
working capital of the Company.

Indicative timeline: 
In connection with the Right Issue, a prospectus (the "Prospectus") will be
prepared which is subject to the approval by the Norwegian Financial Supervisory
Authority (the "NFSA"), expected to be obtained during Q1 2025. The Prospectus
will be published prior to the commencement of the subscription period and will
form the basis for subscriptions in the Right Issue. Provided that the
prospectus is approved by the NFSA in time, the subscription period for the
Rights Issue is expected to commence shortly after approval of the Prospectus. A
further description of the Rights Issue and of other circumstances that must be
considered upon subscription of shares in the Rights Issue will be included in
the Prospectus. 

Included below is an indicative timeline for the Rights Issue: 

o On or about 2 December 2024: Extraordinary general meeting 
o On or about 2 December 2024 2024: Last day of trading in the shares including
subscription rights
o On or about 3 December 2024 : First day of trading in the shares excluding
subscription rights 
o On or about 4 December 2024: Record date for determination of the right to
receive subscription rights 
o On or around 15 January 2025: Effectiveness of the Share Capital Reduction
o Publication of the Prospectus and commencement of the subscription period as
soon as possible following the share 
  capital reduction

ENDS

Geir Johansen, CEO, Arribatec Group ASA: +47 4771 0451 
Martin Nes, Chairman of the Board, Arribatec Group ASA: +47 920 14 814 

About Arribatec | www.arribatec.com
Arribatec is a software and consulting company headquartered in Oslo. With a
customer-centric engagement model combined with a deep system, integration, and
domain competence, Arribatec builds long-term strategic partnerships with a
broad customer base. Arribatec serves more than 1700 companies spread over 25
countries and various industries in the private and public sectors. The company
employs over 350 people with offices in 11 countries and is listed on the Oslo
Stock Exchange under the ticker code ARR.

This information is considered to be inside information pursuant to the EU
Market Abuse Regulation, and was published by Geir Johansen, CEO, on the time
and date provided.